Melissa Conrad
TitleCited byYear
Regressive Evolution in the Mexican Cave Tetra, Astyanax mexicanus
M Protas, M Conrad, JB Gross, C Tabin, R Borowsky
Current biology 17 (5), 452-454, 2007
2022007
Absence of Putative Artemisinin Resistance Mutations Among Plasmodium falciparum in Sub-Saharan Africa: A Molecular Epidemiologic Study
SM Taylor, CM Parobek, DK DeConti, K Kayentao, SO Coulibaly, ...
The Journal of infectious diseases 211 (5), 680-688, 2014
1972014
Multi‐trait evolution in a cave fish, Astyanax mexicanus
M Protas, I Tabansky, M Conrad, JB Gross, O Vidal, CJ Tabin, R Borowsky
Evolution & development 10 (2), 196-209, 2008
1262008
Association between Trichomonas vaginalis and vaginal bacterial community composition among reproductive-age women
RM Brotman, LL Bradford, M Conrad, P Gajer, K Ault, L Peralta, LJ Forney, ...
Sexually transmitted diseases 39 (10), 807, 2012
1092012
Polymorphisms in K13 and falcipain-2 associated with artemisinin resistance are not prevalent in Plasmodium falciparum isolated from Ugandan children
MD Conrad, V Bigira, J Kapisi, M Muhindo, MR Kamya, DV Havlir, ...
PloS one 9 (8), e105690, 2014
1012014
Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis
MD Conrad, AW Gorman, JA Schillinger, PL Fiori, R Arroyo, N Malla, ...
PLoS neglected tropical diseases 6 (3), e1573, 2012
802012
Extensive genetic diversity, unique population structure and evidence of genetic exchange in the sexually transmitted parasite Trichomonas vaginalis
MD Conrad, AW Gorman, JA Schillinger, PL Fiori, R Arroyo, N Malla, ...
PLoS neglected tropical diseases 6 (3), e1573, 2012
802012
Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in …
MD Conrad, N LeClair, E Arinaitwe, H Wanzira, A Kakuru, V Bigira, ...
The Journal of infectious diseases 210 (3), 344-353, 2014
782014
Microsatellite polymorphism in the sexually transmitted human pathogen Trichomonas vaginalis indicates a genetically diverse parasite
M Conrad, Z Zubacova, LA Dunn, J Upcroft, SA Sullivan, J Tachezy, ...
Molecular and biochemical parasitology 175 (1), 30-38, 2011
602011
Synteny and candidate gene prediction using an anchored linkage map of Astyanax mexicanus
JB Gross, M Protas, M Conrad, PE Scheid, O Vidal, WR Jeffery, ...
Proceedings of the National Academy of Sciences 105 (51), 20106-20111, 2008
592008
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda
GW Mbogo, S Nankoberanyi, S Tukwasibwe, FN Baliraine, SL Nsobya, ...
The American journal of tropical medicine and hygiene 91 (1), 54-61, 2014
492014
Temporal changes in prevalence of molecular markers mediating antimalarial drug resistance in a high malaria transmission setting in Uganda
GW Mbogo, S Nankoberanyi, S Tukwasibwe, FN Baliraine, SL Nsobya, ...
The American journal of tropical medicine and hygiene 91 (1), 54-61, 2014
492014
Lack of artemisinin resistance in Plasmodium falciparum in Uganda based on parasitological and molecular assays
RA Cooper, MD Conrad, QD Watson, SJ Huezo, H Ninsiima, ...
Antimicrobial agents and chemotherapy 59 (8), 5061-5064, 2015
482015
Artesunate/amodiaquine versus artemether/lumefantrine for the treatment of uncomplicated malaria in Uganda: a randomized trial
A Yeka, R Kigozi, MD Conrad, M Lugemwa, P Okui, C Katureebe, K Belay, ...
The Journal of infectious diseases 213 (7), 1134-1142, 2015
432015
Getting trichy: tools and approaches to interrogating Trichomonas vaginalis in a post-genome world
MD Conrad, M Bradic, SD Warring, AW Gorman, JM Carlton
Trends in parasitology 29 (1), 17-25, 2013
382013
Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria
H Wanzira, A Kakuru, E Arinaitwe, V Bigira, MK Muhindo, M Conrad, ...
Clinical infectious diseases 59 (4), 509-516, 2014
372014
Impact of antimalarial treatment and chemoprevention on the drug sensitivity of malaria parasites isolated from Ugandan children
P Tumwebaze, MD Conrad, A Walakira, N LeClair, O Byaruhanga, ...
Antimicrobial agents and chemotherapy 59 (6), 3018-3030, 2015
362015
Optimization of a ligase detection reaction-fluorescent microsphere assay for characterization of resistance-mediating polymorphisms in African samples of Plasmodium falciparum
NP LeClair, MD Conrad, FN Baliraine, C Nsanzabana, SL Nsobya, ...
Journal of clinical microbiology 51 (8), 2564-2570, 2013
332013
Changing antimalarial drug resistance patterns identified by surveillance at three sites in Uganda
P Tumwebaze, S Tukwasibwe, A Taylor, M Conrad, E Ruhamyankaka, ...
The Journal of infectious diseases 215 (4), 631-635, 2016
222016
Artemether-lumefantrine and dihydroartemisinin-piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda
AR Taylor, JA Flegg, CC Holmes, PJ Guérin, CH Sibley, MD Conrad, ...
Open forum infectious diseases 4 (1), 2017
192017
The system can't perform the operation now. Try again later.
Articles 1–20